These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30251567)

  • 1. Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line.
    Pellegrini S; Manenti F; Chimienti R; Nano R; Ottoboni L; Ruffini F; Martino G; Ravassard P; Piemonti L; Sordi V
    Cell Transplant; 2018 Oct; 27(10):1548-1560. PubMed ID: 30251567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors.
    Walczak MP; Drozd AM; Stoczynska-Fidelus E; Rieske P; Grzela DP
    J Transl Med; 2016 Dec; 14(1):341. PubMed ID: 27998294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
    Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
    Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells.
    Sebastiani G; Valentini M; Grieco GE; Ventriglia G; Nigi L; Mancarella F; Pellegrini S; Martino G; Sordi V; Piemonti L; Dotta F
    Acta Diabetol; 2017 Mar; 54(3):265-281. PubMed ID: 28039581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Induced Pluripotent Stem Cells from Diabetic Foot Ulcer Fibroblasts Using a Nonintegrative Sendai Virus.
    Gerami-Naini B; Smith A; Maione AG; Kashpur O; Carpinito G; Veves A; Mooney DJ; Garlick JA
    Cell Reprogram; 2016 Aug; 18(4):214-23. PubMed ID: 27328415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of stimulus-secretion coupling in the human pancreatic EndoC-βH1 beta cell line.
    Andersson LE; Valtat B; Bagge A; Sharoyko VV; Nicholls DG; Ravassard P; Scharfmann R; Spégel P; Mulder H
    PLoS One; 2015; 10(3):e0120879. PubMed ID: 25803449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human iPSCs from fetal prostate fibroblasts HPrF.
    Kahounová Z; Slabáková E; Binó L; Remšík J; Fedr R; Bouchal J; Vrtěl R; Jurečková L; Porokh V; Páralová D; Hampl A; Souček K
    Stem Cell Res; 2019 Mar; 35():101405. PubMed ID: 30776675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
    Han MJ; Kim HR; O'Reilly C; Kim CH
    Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA.
    Marzinotto I; Pellegrini S; Brigatti C; Nano R; Melzi R; Mercalli A; Liberati D; Sordi V; Ferrari M; Falconi M; Doglioni C; Ravassard P; Piemonti L; Lampasona V
    Sci Rep; 2017 Oct; 7(1):14051. PubMed ID: 29070792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reprogrammed pancreatic progenitor-like intermediate state of hepatic cells is more susceptible to pancreatic beta cell differentiation.
    Wang Q; Wang H; Sun Y; Li SW; Donelan W; Chang LJ; Jin S; Terada N; Cheng H; Reeves WH; Yang LJ
    J Cell Sci; 2013 Aug; 126(Pt 16):3638-48. PubMed ID: 23750005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
    Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
    Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation of Human-Induced Pluripotent Stem Cells in Chemically Defined Medium.
    Chen G; Rao M
    Methods Mol Biol; 2017; 1590():131-137. PubMed ID: 28353266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.